Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanjeevani Vati is a classical Ayurvedic polyherbal tablet formulation used in traditional medicine for gastrointestinal and febrile conditions, including indigestion, dyspepsia, gastroenteritis, fever, cough, common cold, and respiratory complaints. It is not a modern single-entity pharmaceutical and does not have a validated, discrete molecular target or a standardized modern mechanism of action; instead, it is a multi-ingredient oral herbal-mineral preparation traditionally described as improving digestion, reducing Ama, and supporting recovery from infectious and inflammatory syndromes. Commonly listed ingredients include vidanga, ginger, pippali, haritaki, bibhitaki, amalaki, vacha, guduchi, purified bhallataka, and purified vatsanabha, processed according to Ayurvedic methods including cow urine, and it is manufactured by multiple Ayurvedic companies rather than developed by a single biotech sponsor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanjeevani Vati.